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ABSTRACT OF THESIS 
 
 
ANORGANIC BOVINE HYDROXYAPATITE-PLGA COMPOSITES FOR BONE  
 
TISSUE ENGINEERING 
 
The objective of the present study was to synthesize porous, biodegradable poly (D, l- 
lactide-co-glycolide) PLGA-B-HA (Bovine hydroxyapatite) composite and evaluate the 
effect of ceramic content on bone marrow cell differentiation in vitro. A macroporous 
biodegradable PLGA-B-HA composite with the pore size varying from 0.1 to 1000µ and 
a highly interconnected structure was fabricated using the freeze-drying/lyophilization 
technique. A pilot study was done to determine the effects of B-HA on to the osteoblast 
function. The main study was done to determine the effect of the increase in B-HA 
concentration on to the mesenchymal stem cell differentiation. Morphological 
characteristics of the composites were analyzed using FTIR and SEM/EDX analysis.  The 
composites were seeded with neonatal rat calvarial osteoblasts (NRCO). The polymer: 
ceramic ratio in this study was 35%:65%. For comparison parallel experiments involving 
pure HA-200 discs were performed. SEM results indicated a higher proliferation and 
mineralization on PLGA-B-HA composites than pure HA discs. In addition, we evaluated 
the in vitro characteristics of PLGA-B-HA composites with varying ratios, i.e., 1:1, 1:2 
and 1:3, seeded with rat marrow cells. FTIR indicated an increase in the area under the 
ceramic peak as ceramic concentration was increased. In addition, the average roughness 
values increased in the order of 1:3 > 1:2 > 1:1. Both compressive strength and modulus 
of 1:1 were significantly higher than 1:2 and 1:3 PLGA-B-HA composites. No significant 
difference in compressive modulli and strengths could be observed for 1:2 and 1:3 
PLGA-B-HA composites. Cellular activity was determined by measuring AP activity, 
total protein analysis and osteocalcin concentration. Evaluation of alkaline phosphatase 
activity showed bone cells attached to 1:3 (PLGA-B-HA) expressed significantly higher 
alkaline phosphatase as compared to 1:1 and 1:2 PLGA-B-HA composites. In addition, 
cells seeded on to 1:3 composites secreted significantly higher osteocalcin and at a 
relatively short time period as compared to the other samples. Corrosion studies (ICP) 
and pH values indicate minimal difference in the concentration of Ca and P and pH in 
tissue culture media for all the samples at the end of all time periods. Hence we conclude 
that an increase in the ceramic concentration stimulated mesenchymal stem cell 
differentiation thereby promoting osteogenesis.  
                                                                                                 
KEYWORDS: neonatal rat calvarial osteoblasts, freeze drying, mesenchymal stem cells, 
bovine hydroxyapatite, osteogenesis  
 
                                                                                      Harini Raman  
                       
                                                                                                               06/02/05 
 
                                                                                                 
 
 
 
 
 
 
 
 
 
 
 
ANORGANIC BOVINE HYDROXYAPATITE-PLGA COMPOSITES FOR BONE  
 
TISSUE ENGINEERING 
 
 
 
         By 
 
Harini Raman  
 
 
 
 
 
 
 
 
 
 
 
                                  Dr. Ahmed El-Ghannam   
                  Director of Thesis 
 
               Dr. Abhijit Patwardhan   
                Director of Graduate Studies 
 
              06/02/05   
                                                                                                 
 
 
RULES FOR THE USE OF THESES 
 
 
Unpublished theses submitted for the Master’s degree and deposited in the University of 
Kentucky Library are as a rule open for inspection, but are to be used only with due 
regard to the rights of the authors. Bibliographical references may be noted, but 
quotations or summaries of parts may be published only with the permission of the 
author, and with the usual scholarly acknowledgements. 
 
Extensive copying or publication of the thesis in whole or in part also requires the 
consent of the dean of the Graduate School of the University of Kentucky. A Library that 
borrows this thesis for use by its patrons is expected to secure the signature of each user. 
 
 
 
 
 
 
 
 
                                                               
    THESIS 
 
 
 
 
 
 
 
 
 
 
 
Harini Raman  
 
 
 
 
 
 
 
 
 
 
 
 
The Graduate School 
 
University of Kentucky 
 
2005 
 
 
 
 
 
ANORGANIC BOVINE HYDROXYAPATITE-PLGA COMPOSITES FOR BONE  
 
TISSUE ENGINEERING 
 
 
 
 THESIS 
 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of  
 
Science in the Graduate School at the University of Kentucky 
 
 
 
 
By 
 
Harini Raman  
 
Advisor: Dr. Ahmed El-Ghannam  
 
Lexington, Kentucky  
 
June 2005  
 
 
 
 
 
 
                                             MASTER’S THESIS RELEASE 
 
 
 
 
 
 
 
I authorize the University of Kentucky  
Libraries to reproduce this thesis in whole or part  
 for purpose of research 
 
 
 
 
 
 
 
       
                                          
Signed: 
 
                                           Date:   
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
I would like to thank and extend my gratitude to my advisor and professor, Dr. Ahmed 
El-Ghannam and Dr. David A. Puleo. Their guidance, support and perseverance through 
the course of my research were invaluable. I am thankful to them for having offered me 
such an incredible opportunity. Without their assistance I would not have earned this 
valuable degree. I would also like to thank Dr. Jie Cai who helped me begin my research 
at the University. .  
 
I would like to thank Dr. Conquin Ning, Junaid Mehta and Gautam Gupta for assisting 
me in certain areas of research.    
 
I would like to thank Dr. Scott Stephens for letting me use their laboratory equipment for 
surface roughness measurements. I would like to thank Sriram Venkatesan for assisting 
me with the “New View 5000”.  I would like to thank Larry Rice for helping me with the 
SEM.  
 
Appreciation is also extended to Dr. Charles Knapp, member of the thesis committee, for 
his support and encouragement throughout my degree.  
 
And finally to my mother and father who worked so arduously for me to get here.    
            
            
 iii
 
TABLE OF CONTENTS  
 
ACKNOWLEDGEMENTS        iii  
       
LIST OF FIGURES         vii 
       
LIST OF TABLES         xi 
    
   1. Chapter One: Introduction       1        
1.1 Motivation        1 
1.2 Autologous transplants involving bone marrow stem cells  3 
1.3 Ideal Bone Graft substitute      5 
1.4 Types of Composites used as Bone substitutes    5 
1.4.1 Polymers       6 
1.4.1.1 Properties      6 
   1.4.1.2 Applications      7 
        1.4.1.2.1 Drug delivery     7                 
        1.4.1.2.2 In bone regeneration    8                                  
1.4.2 Calcium Phosphate ceramics     8 
1.4.2.1 Properties      8 
                                         1.4.2.1.1 Comparison of resorption rates of calcium 9  
                                                        phosphate ceramics on osteogenesis  
                                         1.4.2.1.2 Effect of varying porosity of calcium            10  
                                                        phosphate ceramics on osteogenesis  
1.4.2.2. Applications      10 
     1.4.2.2.1 As cell based carriers    10 
     1.4.2.2.2 As a carrier of bone morphogenetic protein 11 
     1.4.2.2.3 As a bone graft substitute in intervertebral  11 
                    spinal fusion          
1.4.3 Polymer-Ceramic composites     12 
1.4.3.1 Properties      12 
     1.4.3.1.1 Effect of varying the pore size   13 
     1.4.3.1.2 Mechanical properties    13 
                                    1.4.3.2 Applications      13         
                                         1.4.3.2.1 As a carrier of bone morphogenetic protein 13 
                                         1.4.3.2.2 In bone regeneration    14 
1.5 Fabrication methods/Processing Methods of porous scaffolds 14                    
1.5.1 Freeze drying/lyophillization technique   15 
                                     1.5.1.1 Processing parameters    15 
                1.5.1.2 Coarsening effect     16 
 
1.6 Objective/purpose of the study     17 
    
 iv
 2. Chapter Two: Materials and Methods      18 
2.1 Preparation of polymer/hydroxyapatite mixture   18 
                2.2 Cell isolation, seeding and culture     20 
2.3 Material characterization      23 
                     2.3.1 Fourier transform infrared spectroscopy analysis (FTIR) 23                                      
                     2.3.2 Electron microscopy      23 
                     2.3.3 Mechanical testing      24 
                     2.3.4 Surface roughness characterization     23 
2.4 Bioactivity evaluation       24 
                     2.4.1 Alkaline phosphatase assay     25 
                     2.4.2 Osteocalcin       26 
                2.5 Corrosion studies in tissue culture medium    26 
                2.6 Statistical analysis       27 
 
 3. Chapter Three: Results        28         
                3.1 Pilot study        28              
                      3.1.1 Characterization of the material     28         
                                    3.1.1.1 External morphology of the PLGA-B-HA  28 
composite         
                                    3.1.1.2 SEM analysis of the composite   30 
 material               
           3.1.2 Cell adhesion and morphology     32  
                                    3.1.2.1 Evaluation of pure HA discs (Interpore 200)  32 
seeded with neonatal rat calvarial osteoblasts                           
                                    3.1.2.2 Evaluation of PLGA-B-HA composites seeded 34 
with neonatal rat calvarial osteoblasts             
    3.2 Main study        40        
           3.2.1 Effect of the chemical composition on the morphology  40 
                    of 1:1, 1:2 and 1:3 PLGA-B-HA composites 
           3.2.2 FTIR analysis       56          
           3.2.3 Mechanical testing      58 
           3.2.4 Biochemical assays      59 
               3.2.4.1 Total protein analysis     59 
                                     3.2.4.2 Alkaline phosphatase assay    61         
                                     3.2.4.3 Osteocalcin      63        
            3.2.5 Corrosion studies in tissue culture medium   64                                       
                                     3.2.5.1 Ca concentration at the end of 28 days  64 
                                     3.2.5.2 P concentration at the end of 28 days  65 
                       3.2.6 pH measurements at the end of 28 days    66
 v
 4. Chapter Four: Discussion        67       
               4.1 Pilot study        67 
                       4.1.1 Significance of Bovine bone hydroxyapatite   67 
                       4.1.2 Significance of copolymer ratio     67 
                       4.1.3 Significance of freeze drying     67 
                       4.1.4 Significance of cell-material interactions   68 
               4.2 Main study        70 
            4.2.1 Significance of surface topography    70  
                       4.2.2 Effect of chemical composition on the morphology of 1:1, 72 
                               1:2 and 1:3 PLGA-B-HA composites                                                                                   
                        4.2.2.1 Surface roughness characterization   72 
             4.2.3 FTIR analysis       75  
  4.2.4 Mechanical testing      75 
  4.2.5 Bioactivity evaluation      76 
                                    4.2.5.1 Alkaline phosphatase assay    76  
                                    4.2.5.2 Osteocalcin      77 
  4.2.6 Corrosion studies in tissue culture medium   79 
 
5. Chapter Five: Conclusions        81 
              
Future work          82 
 
References           83 
 
Vita            94 
 vi
 
LIST OF FIGURES 
 
Pilot study  
Fig.1. Bone marrow stem cell isolation from the femora of 7-week old  20 
          fisher 344 male rats      
Fig.2. External morphology of PLGA/B-HA composite    28  
Fig.3. Higher magnification of the wall of a pore of PLGA-B-HA   29 
           composite          
Fig.4. SEM analysis of PLGA-B-HA composite without cells   30 
Fig.5. EDX analysis of PLGA-B-HA composite without cells   31 
Fig.6. SEM image of the surface of hydroxyapatite ceramic surface cultured 32 
          with neonatal rat calvarial osteoblasts at the end of 2 weeks     
Fig.7. Higher magnification of the surface of hydroxyapatite ceramic  33 
          cultured with neonatal rat calvarial osteoblasts at the end of 2 weeks   
Fig.8. SEM image of the surface of PLGA-B-HA composites cultured with 34 
          neonatal rat calvarial osteoblasts at the end of 2 weeks     
Fig.9. EDX analysis of calcified nodules produced by the neonatal rat  35 
           calvarial osteoblasts on the PLGA-B-HA composites at the end of 2 weeks   
Fig.10.Higher magnification of the surface of PLGA-B-HA composites  36 
           cultured with neonatal rat calvarial osteoblasts at the end of 2 weeks   
Fig.11.EDX analysis of the interaction between the calcified nodules and  37 
           collagen fibers produced by the neonatal rat calvarial osteoblasts  
           at the end of 2 weeks                      
 vii
Fig.12.An area under a crack the cell layer within the pore wall of the  38 
PLGA-B-HA composite seeded with cells       
Fig.13. EDX analysis of the area under a crack in the cell layer within the  39 
pore wall of the PLGA-B-HA composite seeded with cells     
    
 viii
Main study  
Fig.14. External morphology of 1:1 PLGA-B-HA composite   40 
Fig.15. External morphology of 1:2 PLGA-B-HA composite   42 
Fig.16. External morphology of 1:3 PLGA-B-HA composite   44 
Fig.17. Image representing the surface of 1:1 PLGA-B-HA composite  46 
Fig.18. Oblique plot of a randomly chosen area on the 1:1 PLGA-B-HA  47 
            composite as indicated by the arrow (Fig. 17)        
Fig.19. 2-D profile of a randomly chosen area as indicated    48  
by the arrow (Fig. 17)   
Fig.20. Image representing the surface of 1:2 PLGA-B-HA composite.  49 
Fig.21 Oblique plot of a randomly chosen area on the 1:2 PLGA-B-HA  50  
            composite as indicated by the arrow (Fig. 20)       
Fig.22. 2-D profile of a randomly chosen area as indicated    51 
by the arrow (Fig. 20) 
Fig. 23 Image representing the surface of 1:3 PLGA-B-HA composite  52 
Fig. 24 Oblique plot of a randomly chosen area on the 1:3 PLGA-B-HA  53  
            composite as indicated by the arrow (Fig. 23)    
Fig.25. 2-D profile a randomly chosen area as indicated    54 
by the arrow (Fig. 23) 
Fig.26. FTIR spectra of 1:1, 1:2 and 1:3 PLGA-B-HA composites   56     
Fig.27. Protein concentrations in µg/ml produced by rat marrow stem cells  59 
on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the end of 10, 20  
and 30 days    
 ix
Fig.28. AP activity in nmol of pNP/min/µg protein produced by rat marrow 61  
 stem cells at the on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the end 
 10, 20 and 30 days               
Fig.29. Osteocalcin concentration in absorbance units produced by the rat  63 
 marrow stem cells on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the  
            end of 14, 21 and 28 days                 
Fig.30. Ca concentration in TCM resulting from the degradation of 1:1, 1:2 64 
and 1:3 PLGA-B-HA composites at the end of 7, 14, 21 and 28 days                    
Fig.31. P concentration in TCM resulting from the degradation of 1:1, 1:2  65 
            and 1:3 PLGA-B-HA composites at the end of 7, 14, 21 and 28 days       
Fig.32. Schematic representing the comparisons of osteocalcin concentrations 76 
            produced by the rat marrow stem cells on 1:1, 1:2 and 1:3 PLGA-B-HA     
            composites at the end of 14, 21 and 28 days      
 x
                                                   LIST OF TABLES 
 
Table 1.  Average pore wall thickness of 1:1, 1:2 and 1:3 PLGA-B-HA  45         
    composites                                      
Table 2. Statistical comparison of average roughness values of 1:1, 1:2 and 55 
    1:3 PLGA-B-HA composites             
Table 3. IR frequencies of PLGA and hydroxyapatite in the 2000-1000 cm-1 57 
    and 2000-400 cm-1 region        
Table 4. Compressive modulus and strengths of 1:1, 1:2 and 1:3 PLGA-B-HA 58 
   composites                
Table 5. pH of TCM containing 1:1, 1:2 and 1:3 PLGA-B-HA composites and 66 
   control samples incubated in polystyrene dishes at the end of 21 and   
   28 days
 
 xi
CHAPTER ONE 
INTRODUCTION 
 
1.1 Motivation 
Medical procedures relevant to bone related injuries prevalent in the United States with 
over 800,000 grafting procedures are done annually [1].  10% of the bone grafting 
procedures include the use of synthetic graft substitutes. There is a need to develop 
effective bone substitutes to heal large bone defects due to trauma; congenital disorders 
etc. Autografts are tissues taken from the same patient. They are widely in the form of 
cancellous autogenous bone or the gold standard [2]. They are osteogenic, 
osteoconductive and osteoinductive. The presence of surviving cells, osteoinductive 
proteins i.e. bone matrix proteins, mineralized matrix, and collagen supports cell 
function. The limitations include donor site morbidity which includes pain, due to 
grafting and limited availability of the donor organs. The procedure is expensive and may 
be associated with post surgery complications.   
 
Allografts on the other hand are bone graft substitutes that include tissue taken from a 
different patient. The limitations include risk of infection during transplantation process. 
It may also be accompanied with inflammatory reactions and in extreme cases leads to 
graft rejection [2-4]. One case of hepatitis B transmission and 3 cases of hepatitis C 
transmission have been reported with allograft tissue; the latest case occurred in 1992. 
Cases involving HIV transmission have been reported in 2000 [2]. Xenografts include 
transplantation of cells from different species. As with allografts, the major problem is 
related with biocompatibility issues, humans have "natural antibodies" that circulate in 
  1
the blood and cause immediate graft rejection when organs from some species are 
transplanted (for example grafts made from pig organs) [4].  
 
Biomaterials based on polymers, ceramics, metals, bioactive glasses and composites 
materials are used as synthetic bone graft substitutes [1-3, 5-7]. The limitations that 
metals possess include extremely high mechanical properties than bone thereby leading 
to stress shielding, subsequent weakening of the host tissue and making it susceptible to 
fracture. The challenges currently include fabricating a biocompatible substrate that 
provides a surface promoting direct bone apposition that ultimately acts as the true bone 
tissue. Donor organ scarcity limits the number of people who require organ 
transplantation. This problem has urged the development of a substrate that restores the 
function of damaged tissue and enhances reconstruction using the tissue engineering 
approach.  The advantages of this technique include the elimination of repeated surgery at 
the donor site.   
 
The tissue engineered scaffolds must provide 3-dimensional tissue growth providing 
optimal growth space and vascularization. In addition the scaffolds should be 
biocompatible, highly porous and must have non-toxic degradation products. High 
porosity provides sufficient space to promote cell infiltration within the scaffolds. The 
viability of the cells would be maintained by vascularization. The cell viability is 
hindered if the vascularization is improper which is dependent upon the interconnected 
porous network structure of the scaffold [5].  
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1.2 Autologous transplants involving bone marrow stem cells    
In an organism formation of bone takes place during the development of embryo, growth, 
remodeling, fracture repair, and when induced experimentally for e.g. by purified or 
recombinant members of the bone morphogenetic family (BMP). Bone marrow stroma 
contains cells that have both proliferative and differentiative capacity. The differentiative 
ability of the cells enables them to form multiple lineages, e.g. bone, cartilage, marrow 
adipocytes, fibrous tissue and any other tissue in the body. This ability of unlimited and 
extensive regenerative ability is due to regeneration of marrow stroma [8].  
 
The mesenchymal stem cells differentiation into respective osteoblastic lineage or from 
osteoblastic progenitors to an osteoblast starts with multipotential stem cells with an 
unlimited regenerative capacity. The differentiation of multipotential stem cells leads to 
the formation of progenitors for other mesenchymal cells including adipocytes, 
fibroblasts and myoblasts as well as precursors for osteoblasts. They divide further to 
form immature and then mature osteoprogenitors. At this stage these cells have limited 
self regenerative capacity but high rate of proliferation. The mature progenitors 
differentiate to form prosteoblasts which further differentiate into mature osteoblasts. The 
mature osteoblasts divide post mitotically and give rise to osteocytes and eventually 
leading to apoptosis. As the osteoblastic lineage progresses the cells have a limited rate of 
proliferation but an extensive rate of differentiation. This continues till the cells 
differentiate to form mature osteoblasts and which further differentiate to form osteocytes 
[8].  
 
  3
Variety of materials have been researched and incorporated to heal osseous defects. 
These include autogenous and allogenic tissues [8-11]. While surgeons have extensively 
used autograft to deliver osteoblasts to defect sites, the transplantation of in vitro 
expanded osteoprogenitor cells is one of the current areas of focus in research today. In 
vitro cultured human mesenchymal stem cells can synthesize collagenous and 
noncollagenous proteins that are the components of skeletal matrix. A promising 
approach involves the transplantation of human bone marrow stem cells (BMSC’s), 
which have been shown to possess a high osteogenic potential. In order to make BMSC 
transplantation useful as a method for forming new bone to close osseous defects in 
patients, the technique must be improved to optimize the rate, extent of proliferation and 
mechanical strength of the newly formed bone [8].  
 
The development of a suitable matrix that permits the growth of the newly forming bone 
or provides a surface that promotes direct bone apposition is a current focus of research. 
A macroporous structure of the matrix permits extensive vascularization from the host 
tissue and promotes cell viability and function. This further allows the transplant to be 
incorporated in the defect region. This characteristic of the carrier matrix stimulates the 
differentiation of mesenchymal stem cells to their specific osteoblast phenotype [9-10]. 
 
Osteogenic cells derived from rat bone marrow cells were cultured on polymeric two-
dimensional and three-dimensional tissue engineered scaffolds. The results indicated that 
the scaffolds supported osteoblast function by the formation of a mineralized matrix 
directly on the polymer surface. This bone-like apatite layer formed on the surface of the 
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substrate promotes cell attachment and proliferation thereby allowing direct bone 
bonding. The mineralized layer stimulates osteoblasts to secrete collagenous matrix [11].    
 
1.3 Ideal Bone Graft substitute 
The properties of an ideal bone graft substitute include simulating an autograft but 
eliminating the problems associated with it. The scaffold when implanted within the body 
should be biocompatible and bioresorbable with non-toxic degradation by products. It 
should be composed of an osteoconductive matrix that mimics the calcified matrix of the 
tissue and/or contains necessary bioactive factors to make it osteoconductive. This 
includes autogenous osteoblast transplantation on to biodegradable, bioresorbable and 
porous scaffolds. Porosity enables the infiltration of the cells deep within the scaffolds 
and maintains cell viability by promoting vascularization. The transplanted cells may 
secrete new matrix and factors necessary for bone ingrowth while the bioresorbable 
material gradually degrades [9-11].  
 
1.4 Types of Composites used as Bone substitutes  
Composite materials have been widely used in bone reconstruction procedures. They 
include polymer-ceramic composites, polymers composites of PLA, PGA, PLGA, PLLA, 
PDLA, polyurethanes and polycaprolactones etc. or ceramic composites of calcium 
phosphate series that include monocalcium and bi-calcium phosphates, α and β- 
tricalcium phosphates, hydroxyapatite and bioactive glass composites etc. Polymers have 
good mechanical strength but they lack osteoconductivity, on the other hand ceramics are 
osteoconductive but are brittle [1-10, 26, 31, 42]. To address the limitations of individual 
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materials, new materials based on composites of ceramics and polymers have been 
proposed.  
 
1.4.1 Polymers  
1.4.1.1 Properties  
Biodegradable polymers have been observed to support mesenchymal stem cell 
differentiation and in cartilage regeneration [4-7]. Copolymers of two α-polyesters i.e. 
polylactic acid (PLA) and polyglycolic acid (PGA) have been widely used to their 
inherent biodegradable properties. They enhance bone remodeling by transferring 
mechanical load to the surrounding tissues by virtue of degradation. They can be 
completely resorbed within the body and can be eliminated by the normal metabolic 
processes.  
 
The degradation rates of copolymers could range from days to years by varying the ratio 
of lactic acid to glycolic acid. Implants comprising of 100% PLA or 100% PGA degrade 
at a slower rate than the copolymers due to their high crystallinity.  The polymer 
degradation is due to hydrolysis. A crystalline morphology provides a definite structure 
that restricts the penetration of water molecules thereby lowering the degradation rate. 
Since the half life of PGA is shorter than that of PLA; hence increasing the PGA content 
will enhance the degradation process. Other factors that influence the degradation rate 
include viscosity and molecular weight of copolymers. Higher the molecular weight and 
viscosity, slower would be the degradation as compared to low viscosity and low 
molecular weight polymers [7]. 
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1.4.1.2 Applications   
1.4.1.2.1 Drug delivery  
Biodegradable polymers such as poly (DL-lactide-co-glycolide) (PLGA) and polylactides 
(PLA) are widely used for drug delivery due to their controlled degradation and 
biocompatibility within the host tissues. [12]. In addition the major advantages of 
biodegradable drug delivery systems involving hydrolyzing polymers is the elimination 
of reoperation rates. The degradation by products are non toxic and can be eliminated by 
the body easily which may not be the case for polymers like polyurethanes etc [12-13].  
 
The distribution of the encapsulated drug within the polymeric phase would be influenced 
by drug’s solid-state solubility and by the ability of the polymeric matrix to entrap drug 
in dispersed state. An increase in the lactide content leads to the increase in 
hydrophobicity and facilitates relatively higher solubility of a hydrophobic drug within 
the hydrophobic phase. The release of drug is governed by its separation from the 
polymeric phase and the surrounding aqueous environment. Higher the solubility of the 
drug within the polymeric matrix, lower is the separation of the drug from the polymer to 
the external aqueous phase. This results in lower rates of drug release. The drug release 
from the biodegradable polymers i.e. PLGA/PLA polymers in the form of nano and 
microparticles comprises of an initial controlled release phase followed by a slow release 
period and a second release phase, which is characterized by the bulk degradation of the 
polymer matrix [12, 14-15 ].  
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1.4.1.2.2 In Bone regeneration  
Several studies have shown use of PLGA as a scaffold to induce new bone tissue 
formation [1, 3-11, 13, 17]. The advantages of using PLGA as a scaffold for bone 
regeneration include 1) fabricated in different shapes; 2) the degradation time, 
mechanical strength, and flexibility can be easily modulated by altering the copolymer 
ratio; 3) even distribution of the cells throughout the scaffold thereby enhancing 
osteogenesis throughout the system.  
 
1.4.2 Calcium Phosphate ceramics 
1.4.2.1 Properties  
Calcium phosphate ceramics have been widely used in tissue engineering applications 
due to the following reasons; a) they have a chemical composition similar to the 
inorganic component of bone; b) have high CaO contents and have been reported to have 
good bioactivity, and the osteoblasts can readily form mineral deposits on the surfaces of 
CP’s in vitro and in vivo; c) induces the formation of bone like apatite layer thereby 
providing direct bone bonding on to the surface unlike non bioactive materials. The 
resorption rates of calcium phosphate ceramics have been studied widely. Resorption rate 
of calcium phosphate ceramics depended on the form, chemical composition, porosity 
(macro and micro), dissolution in the environment and cell mediated resorption. [16, 18-
21].  Resorption of calcium phosphates promoted bone formation [20, 25-26]. The free 
Ca+2 ions released in the surrounding environment during the dissolution process have 
been shown to induce bioactivity [22, 24-25]. 
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1.4.2.1.1 Comparison of resorption rates of the calcium phosphate ceramics on 
osteogenesis 
 Dissolution and precipitation reactions occurring on the surface of calcium phosphate 
ceramics leads to the formation of an apatite layer that would stimulate osteoblast 
migration and function. Yuan et al. observed more bone ingrowth at the end of 150 days 
within the porous β- TCP, whereas no bone in growth could be observed in the case of α-
TCP at the same time period [26]. Higher porosity facilitates dissolution/precipitation and 
thereby mediating cell migration and function. Differences in bone formation could be 
attributed to the differences in dissolution rates of the ceramics. β- TCP resorbs at a 
slower rate as compared to α-TCP. But at longer time in vivo, β- TCP becomes more 
resorbable. Dissolution/precipitation reactions at the ceramic-media interface results in 
the formation of a bone-like apatite layer that promotes otseogenesis. Higher dissolution 
of the ceramic for e.g. i.e. α-TCP could cause an increase in the local concentration of 
Ca+2 and PO4 -3 thereby resulting in an increase in the local pH that may be unfavorable 
to the surrounding environment. This may further hinder bone formation. Lower 
dissolution of the ceramic reduces leads to decreased bioactivity as in the case of β –TCP 
thereby hindering the already formed new bone on to the implant surface.  Degradation of 
ceramics could be altered depending upon the type and structure of the ceramic that is 
being used thereby affecting the new bone formation. 
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1.4.2.1.2 Effect of varying porosity of calcium phosphate ceramics on osteogenesis 
Effects of varying the sintering temperature onto the morphology of different ceramics 
were studied. deGroot et al. investigated the influence of surface modifications on the 
osteoconductive properties of two types of calcium phosphate ceramics (HA and β- TCP) 
[31]. HA was sintered at 1150 and 12500 C. β- TCP consisted a blend of β- TCP and HA 
was sintered at 1100, 1150 and 12000 C. The results indicated that changes in sintering 
temperatures did not influence the ceramic chemistry and the blend composition. 
Increasing the sintering temperature resulted in a decrease in microporosity with 
macroporosity not being affected. An increase in microporosity within a macroporous 
structure increases the specific surface area available for cell material interactions thereby 
triggering the cells to differentiate into the osteoblastic phenotypes.  
 
1.4.2.2 Applications   
1.4.2.2.1 As cell-based carriers  
Ti carriers have been used as because of their biocompatibility and excellent mechanical 
properties [27-30]. Ti-fiber mesh implants and ceramic implants (60% HA and 40% α-
TCP) were incorporated with rat bone marrow stem cells and implanted subcutaneously. 
New bone formation at the end of 1, 3 and 6 weeks in the case of ceramics grew up by 
18% as compared to Ti-fiber meshes which grew up by 10%. Calcium phosphate 
ceramics could be designed as a carrier system so as to deliver cells in the host site due to 
significantly higher bone formation as compared to Ti implants.  
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1.4.2.2.2 As a carrier of Bone morphogenetic protein  
Calcium phosphate ceramics were investigated in vitro and in vivo as a delivery system 
for bone morphogenetic proteins to induce bone formation in soft tissues. The 
significance of BMP in calcium phosphate ceramics has been evaluated [32]. In vitro 
experiments, studies have shown that BMP mixed with calcium phosphate ceramics can 
induce rapid bone formation [33-34] and the bone formation was significantly higher than 
that of BMP alone [33]. Enhancement of bone formation was seen in calcium phosphate 
ceramics incorporated with b-BMP (Bovine-BMP). It was observed that the b-BMP from 
the b-BMP solution in vitro was not only absorbed on to the calcium phosphate ceramics 
and but it also adsorbed native BMP from in vivo fluids [32]. This shows a significant 
role of BMP in calcium phosphate ceramics in osteoinduction. The native BMP 
adsorption from the in vivo body fluids would induce osteogenesis by calcium phosphate 
ceramics.  
 
1.4.2.2.3 As a bone graft substitute in intervertebral spinal fusion  
Calcium phosphate ceramic composites incorporated with mesenchymal stem cells 
provide an alternative to autogenous graft materials for lumbar interbody spinal fusion. 
Efficacy of bone marrow stem cells seeded on to calcium phosphate ceramics as bone 
graft substitutes in a lumbar intervertebral spinal fusion process in rabbits were studied 
[35].  
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1.4.3 Polymer-Ceramic composites (Bone substitute composites)  
1.4.3.1 Properties  
The advantages of combining a biodegradable polymer (PLGA) with a ceramic (HA) are 
used in tissue regeneration due to the following reasons, Improved mechanical properties 
of the composite, enhanced osteoconductive properties of the polymer and  due to the 
buffering action on the acidic degradation byproducts from polyesters. Hydoxyapatite 
ceramics are least soluble as compared to other CP ceramics. Due to its stability and 
controlled degradation rate it could be used in vivo to give sufficient time to heal the 
defect stimulating simultaneous degradation in a controlled manner [36-37, 41-45]. Bone 
grafting materials may produce bone formation by osteogenesis, osteoinduction, 
osteoconduction or osteotransduction. Osteogenesis is a process that includes provision 
of osteogenic cells and matrix directly on to the graft; osteoinduction implies that the 
chemotaxicity of the grafted material attracts the undifferentiated osteoprogenitor cells in 
the host to the site of the graft and stimulates them to differentiate in to osteoblasts, e.g. 
the use of bone morphogenetic protein; osteoconduction is a process that permits 
outgrowth of osteogenic cells from existing bone surfaces into adjacent graft material e.g. 
Calcium phosphate ceramics etc; and osteotransduction involves replacing a bone 
substitute directly by bone [51]. 
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1.4.3.1.1 Effect of varying the pore size  
Pore size is one major factor that controls the osteoblast proliferation or function in vitro. 
For bone ingrowth, an optimum pore size of 200-400 microns has been observed. Pore 
size 200-400 µm provides optimal compression and tension on the osteoblast’s 
mechanoreceptors thereby promoting osteoblast function. This property stimulates 
extracellular matrix secretion by the osteoblasts thereby inducing osteogenesis [36]. 
 
1.4.3.1.2 Mechanical properties  
Mikos et al. studied hydroxyapatite reinforced poly (α-hydroxy ester) foams for bone 
regeneration [37]. In this study low- and high-porosity composite foams PLGA and short 
fiber hydroxyapatite ceramics were synthesized using the solvent casting particulate 
leaching method. Incorporation of HA increased the compressive yield strengths of both 
poly (α-hydroxy ester) foams [41-43].  
 
1.4.3.2 Applications   
1.4.3.2.1 As a carrier of bone morphogenetic protein    
Polymer-ceramic composites were developed as carrier systems to deliver bioactive 
molecules at targeted region to enhance osteogenesis [38-40].  Miki et al. evaluated 
osteoinductive potential of PLGA/HA incorporated with BMP-2 in skull defects of rats. 
Post implantation studies showed that the discs completely resorbed after 4 weeks and the 
defect was filled with new bone. In contrast composites incorporated in defects without 
BMP-2 were filled with fibrous connective tissue. 
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1.4.3.2.2 In Bone regeneration 
Besides their osteoconductive effect, ceramics have shown to neutralize the acidic 
degradation products of PLA thereby improving the biocompatibility of the polymer [26, 
31, 41-42]. Therefore their presence would be effective particularly during the 
degradation of the polymer [41-42].  Most importantly in vitro culture studies showed 
that cell survival percentage on the PLLA-HA (polymer-ceramic) scaffolds significantly 
improved over the pure PLLA scaffolds. Calcium hydroxyapatite ceramics (CHA) are 
nontoxic materials and cause minimal inflammatory reaction [44]. When the porous 
composites were implanted into a rabbit femoral condyle, bone and bone marrow with 
extensive vasculature formed deep in pores through the interpore connections. Excellent 
interconnectivity enables osteoconduction thereby promoting cells and tissues to migrate 
deep in to the pores.  
 
1.5 Fabrication methods/Processing Methods for porous scaffolds  
Various methods involving fabrication of low density porous polymeric scaffolds have 
been synthesized by methods including solution casting/salt leaching, solvent evaporation 
technique, freeze immersion, phase separation, gel casting, emulsion freeze drying, gas 
foaming and fiber binding meshes. Solvent evaporation techniques typically produce 
sacffolds exhibiting smaller pore sizes (1-20 µm). Solvent casting particulate leaching 
method creates desirable pore size ranges by incorporation of the porogen; sieved NaCl 
or soluble sugar particles of a desired size. The pore size and the porosity are determined 
by the particle size and number of particles of the porogen within the polymer. However, 
the significant loss of hydrophillic bioactive agents (e.g. drugs, antibiotics, growth factors 
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incorporated into the foam during the fabrication process would occur during the leach-
out process [45-48].  
 
1.5.1 Freeze drying/Lyophilization technique 
1.5.1.1 Processing Parameters  
Several studies have indicated the synthesis of macroporous scaffolds possessing a 
desired pore range and interconnected porous network [47-49]. Processing parameters 
included solvent composition, polymer concentration, freezing temperature, polymer type 
and polymer molecular weight were optimized to arrive at a desired microstructure with 
an interconnected network that would promote cellular growth and tissue integration.  
 
As the freezing temperature increases, the nucleation rate increases and this results in the 
formation of large number of small crystals of the solvent. And rapid evaporation of the 
solvent leads to the formation of a microporous structure. Hence the microporosity can be 
controlled by the quenching rate of the solvent. Also the solvent/non solvent ratio is also 
an important determinant for obtaining a three-dimensional interconnected network. 
Increasing the non solvent concentration leads to the formation of loose polymer 
particulates with weak strengths were obtained. Porosity decreased by doubling the 
polymer concentration. Very low polymer concentrations resulted in producing structures 
with low mechanical strengths [47-49]. The porosity and density of the foams depend on 
the molecular weight of the polymer chosen. Ma et al. showed that the density of the 
PLGA-HA foams increased with the increase in the polymer to ceramic ratio [49]. At the 
same time the porosity decreased as the polymer and the ceramic content were increased. 
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As the polymer concentration was increased (2.5% to 7.5%), foams with thicker pore 
walls and high mechanical strengths were obtained. As the polymer concentration was 
decreased there was a suspension of the HA particles settled within the polymer particles 
thereby forming a non-uniform solution [49]. 
 
1.5.1.2 Coarsening effect 
Coarsening (coalescence of the phase separated droplets) continuously proceeds to reduce 
the free energy associated with the interfacial area [50]. Macroporous scaffolds could be 
obtained using the coarsening effect, which induces enlargement of the pores. The 
coarsening time decreased with the increasing quenching temperature (temperature to 
which the samples were exposed).  
 
The coarsening effect was predominant in the core of the structures resulting in a 
microporous structure than the surface thereby resulting in a macroporous surface. 
Increasing the amount of water in the solvent mixture tended to generate large cellular 
pores. This could be due to the fact that as the non solvent volume increases, a weaker 
polymer-solvent interaction occurs which might induce the formation of poor phase with 
greater solvent droplet domains. Increasing the quenching temperature induces the 
coarsening effect thereby leading to the formation of enlarged pores with closed cellular 
structures. As the amount of water incorporated into the solvent mixture was increased 
closed cellular macropores upto 1000 µm were obtained [50].  
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1.6 Objective/Purpose of the present study 
The broad goal of this project is to synthesize porous resorbable bioactive B-HA-Polymer 
composite that can be used as a tissue engineering scaffold to deliver bone marrow cells. 
The objective of the present study is to synthesize a porous, biodegradable PLGA- B-HA 
composite and evaluate the effect of ceramic content on bone marrow cell differentiation 
in vitro. The synthesized macroporous polymer-ceramic scaffold with an interconnected 
porous network eventually would enhance bone marrow stem proliferation and 
differentiation in to osteoblastic phenotypes that can be used in treating bone defects.  
 
We have used deproteinized bovine bone hydroxyapatite (B-HA) for the study. Studies 
have shown that, it is a safe and a biocompatible bone graft material [53] and is of 
osteoconductive nature [51, 53]. It is obtained from two different bone types, cortical and 
cancellous bone and commercially available in two particle sizes 0.25-1 mm and 1-2 mm 
[51]. The PLGA-B-HA composites were fabricated using the freeze drying/solid-liquid 
phase separation technique. The study was done in order to determine the effect of 
increase in ceramic concentration on osteoblast activity. Polymer used for the study is 
Poly-D, L-lactide-co-glycolide (50:50) with a molecular weight 50-70,000 Da. This 
polymer was chosen due to its controlled degradation 6 months- 1year.  The polymers 
can be tailored to degrade between weeks to years depending upon their copolymer ratio, 
which can be used to balance the rate of osteoblast growth and ECM deposition on to the 
degradation rate of the material.  
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CHAPTER TWO  
MATERIALS AND METHODS 
 
2.1 Preparation of Polymer/Hydroxyapatite mixture  
Deproteinized bovine hydroxyapatite (B-HA) was prepared and used for the study. The 
structure of the B-HA was confirmed by X-ray diffraction analysis. Bovine 
Hydroxyapatite (B-HA) particles were sifted in the size range (20 < x < 38) microns. 
Poly (D, L-lactic-co-glycolic acid, lactide:glycolide ratio 50:50 (PLGA)  with IV 
(Intrinsic viscosity) = 0.58 and Mw = 50,000-70,000 Da (Sigma, St. Louis, MO). The 
scaffolds were prepared using the freeze drying/Lyophillization techniques. Bovine bone 
was sintered at 10000 C to evaporate the organic material. After the evaporation of the 
organic matrix, the residual matrix is the porous inorganic matrix which was used for the 
study.  The B-HA ceramic particles were first crushed and sifted to obtain the particle 
range (20 < x < 38) µm. 0.73g of the polymer was mixed with 1.2g of sifted B-HA 
particles in a 25 ml centrifuge tube followed by the addition of 8ml of chloroform. The 
solution was allowed to stand for 24 hours for complete dissolution of the polymer. The 
mixture was vortexed for 5-6 minutes till the polymer was dissolved completely so as to 
obtain a uniform suspension of the ceramic particles within the polymer solution. The 
mixture was transferred in to glass vials and stirred for 5 minutes using a magnetic stirrer 
followed by drop wise addition of 2 ml of water. The solution was transferred in to 
plastic moulds and placed in a dry ice container for 2 hours. The samples were in 
specimen of 2 x 2 x 1.5 cm. They were stored in vacuum until use. A pilot study was 
intended to test the effect of the ceramic (bovine hydroxyapatite) on osteoblast function. 
From the results of the pilot study we designed the main study. The main study was 
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designed to study the effect of increase in the ceramic concentration on bone marrow 
stem cell differentiation. 
 
The plastic moulds were lyophilized for about 24-48 hours to ensure complete 
evaporation of the solvent. Similarly we initially weighed the polymer (1g) and ceramic 
(1g) and mixed the two powders and prepared PLGA-B-HA composites (1:1, 1:2 and 1:3) 
in a similar manner as described above. The samples were cut using a razor blade in the 
dimensions of 12 x 11 x 2 mm. Prior freezing in liquid nitrogen was not done for this 
study as it was understood that this mechanism could disrupt the morphological structure 
of the composite.  
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2.2 Cell isolation, seeding and culture  
Fig. 1 Represents the isolation procedure of rat marrow stem cells.  
 
 
Figure 1. The isolation technique of bone marrow stem cells from the femora of 7-week 
old Fisher 344 male rats.  
The two different types of cells that are used for this experiment were the neonatal rat 
calvarial osteoblasts (NRCO) and bone marrow stem cells (BMSC’s). Neonatal rat 
calvarial osteoblasts were isolated using a collagenase digestion technique. Two T-25 
cm2 flasks containing 50 ml of PBS 50 and 34 µL of antibiotic respectively are taken. 
Neonatal rat calvarial cells were isolated and cultured in the flask containing 50 µL of 
antibiotic solution. The flask cap is then tightened and placed and in an ice box. Calvaria 
from the brain tissue are cleaned in a sterile petridish and are made free from the extra 
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tissue. The tissue is then transferred into 50 ml PBS solution prepared earlier. The PBS is 
then pipetted out from the flask without disturbing the cleaned calvarial tissue.  5 ml of 
collagenase-2 is added and is followed by the addition of 1 ml of trypsin. The flask cap is 
tightened and stirred for 20 minutes and the solution is transferred in centrifuge tubes. 
The tubes were centrifuged 400g for 10 minutes. The supernatant containing the enzyme 
is transferred to the flask containing calvarial tissue and the cell pellet from the first 
extraction is discarded. The second extraction was discarded and cells from subsequent 
extractions were used for the experiment. For the third extraction the supernatant was 
transferred in a tube and centrifuged at 400g for 10 minutes. The supernatant was 
removed and 2 ml of media containing 10% Fetal Bovine Serum (FBS), 0.06% 
fungizone, 0.1% antibiotic (penicillin) were added. The cell pellets are broken by 
repeated pipetting and are further cultured in T-75 cm2 flasks in the incubator. The media 
was changed after every 2-3 days. The cells were maintained in T-75 cm2 flasks. α 
Minimally Essential Medium (αMEM) (Invitrogen Technologies, Grand Island, NY) 
containing 10% Fetal Bovine Serum (FBS), 0.06% fungizone, 0.1% antibiotic (penicillin) 
was used in vitro cell culture experiments.  
 
The samples were initially sterilized in 70 % ethanol for 2 ½ hours. The cells were seeded 
on to the scaffold giving a concentration of 50,000 cells/scaffold. The samples (positive 
and negative control) were cultured in a 24-well plate immersed in 2 ml of media. The 
other well plate consisted of pure HA (Interpore 200) seeded with NRCO immersed in 
tissue culture medium. The cells were cultured for a period of 2 weeks and morphology 
was analyzed using SEM/EDX.  In the other study bone marrow stem cells were isolated 
from the femora of 7-week old 344 Fisher male rats. Following euthanasia by CO2 
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inhalation, the femurs were aseptically excised, cleaned of soft tissue, and washed in 
αMinimally Essential Medium (αMEM) (Invitrogen Technologies, Grand Island, NY) 
containing 10% fetal bovine serum (FBS), 0.06% fungizone, 0.1% antibiotic (penicillin) 
and 3mM Na β-glycerophosphate (Sigma). Essential Medium (αMEM) containing the 
above mentioned composition along with 50 µg/mL L-Ascorbic acid (Sigma) and 10-8 M 
dexamethasone (Sigma) was used in vitro cell culture experiments. The metaphyseal ends 
were then cut off and the marrow was flushed from the midshaft with 5-6 ml of media 
using a syringe equipped with an 18 ½ G needle and collected in a sterile petridish. Cell 
clumps were broken by repeatedly pipetting the cell suspension using 20 ½ G, 22 ½ G 
and 23 G needles. The cells then were centrifuged at 500g for 5 min. The resulting cell 
pellets were resuspended in 13 mL of media and plated in T-75 flasks (cells from two 
femurs per flask). After 24 hours, hematopoietic cells and other unattached cells were 
removed from the flasks. Once 70% confluency was reached the cells were enzymatically 
lifted using 5-6 mL trypsin per flask. The cells were concentrated by centrifugation at 
500g for 5 min and resuspended in 2 mL media. Cells were counted with a 
hematocytometer in complete media [consisting of α- MEM supplemented with 10% 
FBS, 3mM Na β-glycerophosphate, 50 µg/mL L-ascorbic acid (Sigma)] containing 10-8 
M dexamethasone (Sigma) to promote the differentiation of bone marrow stromal cells to 
osteoblastic phenotypes. Aliquots of cell suspensions were seeded onto the top of 
prewetted foams placed in the wells of 24 well plates, resulting in seeding densities 
equivalent to 250,000 cells/scaffold. The 24-well plate was left undisturbed in the sterile 
hood for 6 min to allow the cells to attach after which an additional 2 ml of complete 
media was added. Media was replaced after every 2-3 days. The control was used as a 
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comparison for the alkaline phosphatase activity and for a qualitative assessment of the 
mineralization. 
 
2.3 Material Characterization 
2.3.1 Fourier transform infrared spectroscopy Analysis (FTIR)  
1:1, 1:2 and 1:3 PLGA-B-HA composites were analyzed using Fourier Transform 
Infrared Spectroscopy. The data was collected using the Nexus 670 (Thermo Nicolet Inc) 
using KBr as the background. The samples are placed within the sample holder and the 
characteristic peaks are analyzed using the diffuse reflectance method.  
 
2.3.2 Electron microscopy  
PLGA-B-HA composites and pure HA discs seeded with and without cells were analyzed 
using Scanning Electron Microscopy. Samples with cells are repeatedly washed with PBS 
in a 24 well plate to remove the unattached substrates on to the surface. The samples are 
placed in a fixative (10% formaldehyde or glutaraldehyde) and stored in the refrigerator. 
Further they are dehydrated in ethanol series (50%, 60%, 70%, 80%, 90%, 95% and 
100%). The samples were dehydrated in 50-70% for at least 5 minutes and 10 minutes for 
the rest.  The samples are then rinsed in Fluorotrichloromethane (Fereon) and coated with 
gold palladium prior to SEM analysis. The SEM is a Hitachi Model S-3200-N with a 
resolution of 3.5 nm. It is equipped with a Noran Energy Dispersive Spectroscopy {EDS} 
system, which permits elemental analysis down to Boron. The Sputter Coater is a model 
SC - 400 Emscope. The target material is AuPd. We sputter with argon at a pressure of 
0.07 Torr for a period of one minute. 
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2.3.3 Mechanical testing  
The compressive mechanical properties of the composites were tested with a custom built 
Compression testing machine (Center for Biomedical Engineering, University of 
Kentucky, Lexington, KY). The displacement rate was set at 0.5 mm/min. At least 3 
specimens were tested for each sample. The results were expressed as means ± standard 
deviations. 
 
2.3.4 Surface roughness characterization  
2.3.4.1 Qualitative analysis of surface roughness  
The ZYGO New View 5000 scanning white light interference microscope and scanning 
electron microscopy were used to characterize surface roughness.  A qualitative analysis 
of the roughness was performed by scanning electron microscopy (SEM). The SEM is a 
Hitachi Model S-3200-N with a resolution of 3.5 nm.  
 
2.3.4.2 Quantitative analysis of surface roughness  
Quantitative analysis of the roughness was performed by the ZYGO New View 5000 
scanning white light interference microscope (ZYGO Corporation, Middlefield, CT, 
U.S.A). The New View is a precision microscope which uses scanning white light 
interferometry to generate quantitative three dimensional images. Zygo’s MetroPro TM 
software provides an interactive window display, surface images, plots and data. PLGA-
B-HA composites 1:1, 1:2 and 1:3 respectively were coated with aluminum. The PLGA-
B-HA composites were coated with aluminum using a sputtering machine (AJA 
International, Kurt Lesker Inc.) with a coating time and thickness 230 seconds and 20 nm 
respectively at 3 millitorr pressure. 10 readings representing approximately an area of 1 x 
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200 µm were performed randomly corresponding to the different areas on the samples.  
2.5X Mich (10X) were used with image zoom to measure the samples. Surface roughness 
values were expressed as average roughness (Ra), root mean square roughness (Rrms) 
and peak value (Rp).  Rrms values give a good general description of the structure of the 
actual surface. Ra is the arithmetic mean of the departures of the roughness profile from 
the mean area.  
 
 (1) 
Where Zi is the ith dot of the distance to the center line, n is the total number of sampling 
dots, and Rrms, is the root mean-square deviation from the profile mean over the 
sampling area, corresponding to Ra [54]: 
 
 
   (2) 
 
PV (Peak-to valley) is the distance between the highest and the lowest points within the 
sample [55-56]. In the current study Ra, Rrms and Rp values were calculated directly by 
New View software. 
 
2.4 Bioactivity Evaluation  
2.4.1 Alkaline phosphatase assay  
Production of alkaline phosphatase (ALPase) was measured spectroscopically. 
Osteoblast-seeded foams and 2-D osteoblast cultures at the end of 10, 20 and 30 days 
were washed with PBS and lysed using 1% Triton-X 100 (Aldrich Chemical Company 
Incorporation) and the osteoblasts of the 2-D control cultures were scraped from the well 
bottoms, using disposable cell scrapers, into 500 µL 1 % Triton-X 100. The sets were 
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sonicated (FS 30, Fisher scientific incorporation) at 1300 rpm for 3min. The supernatant 
was removed and transferred in new sets of micro tubes. The scaffolds were resuspended 
in 500 µL 1 % Triton-X 100 and the same procedure was followed. The two supernatants 
were combined and the resultant was used to measure the AP assay. The production of p-
nitrophenol in the presence of phosphatase substrate (Sigma, Inc.) was measured by 
monitoring light absorbance by the solution at 410 nm at 5min increments. The slope of 
the absorbance versus time plot was used to calculate the ALpase activity. 
 
2.4.2 Osteocalcin 
Bone marrow stem cells extracted from 7-week old Fisher 344 male rats were grown to 
confluence (day 30) in culture medium. The medium was collected and stored at -20o C 
until assay for osteocalcin. Osteocalcin concentration for 1:1, 1:2, 1:3 and control 
samples was measured at the end of 14, 21 and 28 days respectively in tissue culture 
medium. Determination of osteocalcin was performed in duplicate with an ELISA assay 
(Biomedical Technologies Incorporation, MA, U.S.A); the detection range of the kit was 
0.3-20 ng/ml. 
 
2.5 Corrosion studies in tissue culture medium  
The degradation rates were measured for 1:1, 1:2 and 1:3 PLGA-B-HA composites at the 
end of 7, 14, 21 and 28 days by Optima 2000 DV used for ICP analysis. Four replicates 
of each composition i.e. 64 samples in total were analyzed. pH measurements were taken 
at the end of 28 days following immersion. The samples were diluted in 1:4 dilutions 
using deionized water. The washing solution used in the experiment was 4% HNO3. The 
samples were analyzed for Ca and P concentrations respectively.  
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2.6 Statistical analysis 
Two-way ANNOVA (assuming unequal variances) was performed to determine the 
statistical significance (p < 0.05) in the mean value of measured parameters between the 
different experimental groups.   
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CHAPTER THREE 
RESULTS 
3.1 Pilot study  
3.1.1 Characterization of the material  
3.1.1.1 Surface morphology of PLGA-B-HA composite  
SEM analysis indicated the external morphology of the PLGA-B-HA composite is highly 
porous with the pore size varying from 30-1000 microns (Fig. 2). The arrows point to the 
different pore sizes. 
 
1mm 
Figure 2.  External morphology of the PLGA-B-HA composite. The SEM analysis 
showed that the composite is highly porous with the pore size varying from 30-1000 
microns. The arrows point to pores of various sizes.   
 28
 
Higher magnification indicated that the inner walls of the composite were also porous 
with the pore size varying from 20-1000 nm (Fig. 3). This indicates that the composite 
has an open or an interconnected morphology. Also, we could observe a uniform 
distribution of ceramic particles within the polymeric phase as indicated by the arrows. 
 
10µm 
Figure 3. Higher magnification of the wall of a pore as indicated in Figure 2. The inner 
surface is also porous with the pore size varying from 20-1000 nm. The arrows indicate 
the homogenous distribution of the ceramic particles and this is the surface where the 
cells are getting attached to.  From the figure we can draw a conclusion that the scaffold 
acquired an open porous structure with an interconnected pore network.  
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3.1.1.2 SEM analysis of the composite material 
SEM analysis (Fig.4) shows the ceramic particles (arrows) were covering the surface of 
the surface of the pores.  
100µm 
 
Figure 4.  SEM analysis of the PLGA-B-HA composite without cells. The figure 
indicates the uniform distribution of the ceramic particles on the polymeric matrix. The 
arrows point to B-HA particles. 
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EDX analysis shows a Ca/P ratio of 1.67 (Fig.5). This ratio confirms the presence of the 
HA ceramic incorporated in the polymer. 
 
 
 
 
 
Figure 5.  EDX analysis of PLGA-B-HA composite without cells. The Ca/P ratio in this 
case is equal to be 1.67. The EDX analysis indicated the high Ca and P content indicating 
that these are the ceramic particles. 
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3.1.2 Cell adhesion and Morphology  
3.1.2.1 Evaluation of pure HA discs (Interpore 200) seeded with neonatal rat 
calvarial osteoblasts   
SEM analysis after 2 weeks in culture showed neonatal rat calvarial osteoblasts attached 
to the surface of the ceramic and formed unmineralized cell layer. Fig. 6 is an SEM 
analysis of the cell layer demonstrating that the surface of the cell is smooth and void of 
any calcified nodules. Beneath the non mineralized cell layer ‘C’, a dense collagenous 
matrix is observed.  
 
C
C
C 
1mm 
Figure 6.  SEM image of the hydroxyapatite ceramic surface cultured with neonatal rat 
calvarial cells for 2 weeks. The figure indicated the formation of a cell layer (c) with 
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unmineralized extracellular matrix. It is worthy to note the absence of calcified nodules 
on the cell surface.  The arrows point out to the collagenous matrix beneath the cell layer.  
 
At some places a network of collagen fibers could be observed (Fig. 7) whereas at some 
places we could observe the fusion of the collagen fibers to form a dense layer of ECM. 
An important thing to be noted here is the absence of calcified nodules or mineralized 
matrix.  
 
10µm 
Figure 7.  Neonatal rat calvarial cells cultured on to the surface of HA ceramic for 2 
weeks. In some areas non mineralized collagen fibers were seen covering the surface and 
forming a network. Collagenous fibers network fused together in some areas to make a 
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continuous sheet of ECM on the ceramic surface. It is worth to note the complete absence 
of calcified nodules.  
 
3.1.2.2 Evaluation of PLGA-B-HA composites seeded with neonatal rat calvarial 
osteoblasts  
 SEM analysis indicated (Fig.8) that neonatal rat calvarial osteoblasts attached to PLGA-
B-HA composites formed mineralized extra cellular matrix and calcified nodules after 2 
weeks in culture.  
 
10µm 
Figure 8. Neonatal rat calvarial cells cultured on to PLGA-B-HA composites for 2 
weeks. In contrast we could observe a dense mineralized, extracellular matrix formation 
or calcified nodules on to the surface of the collagenous matrix. Calcified nodules are 
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seen to be deposited on the surface of the collagen fibers as well as the bone like tissue. 
Also at some areas we could observe interaction between the calcified nodules and the 
collagenous fibers as indicated by the arrows. Mineralized extracellular matrix filled the 
pores and covered the surface of the template.  
 
Fig. 9 represents EDX analysis of the calcified nodules produced by the neonatal rat 
calvarial cells cultured on PLGA-B-HA composites for 2 weeks. The Ca/P ratio as 
indicated in the figure is equal to 1.66.  
 
 
Figure 9. EDX analysis of the calcified nodules produced by the cells on the PLGA-B-
HA composite surface. The EDX analysis of the calcified nodules showed a Ca/P ratio of 
1.66. 
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Fig. 10 indicates the higher magnification of the calcified nodules. The arrows indicate 
the immediate interaction between the calcified nodules and the collagen fibers. The 
calcified nodules varied in the size range from 50-500 nm. Large numbers of calcified 
nodules were seen covering the extracellular matrix (collagen fibers) in certain areas on 
the composite surface. 
5µm 
HA 
 
Figure 10.  Higher magnification indicating the formation of a mineralized (ECM) layer 
secreted by the cells seeded on to the PLGA-B-HA composite. In some places we can 
observe accumulation of calcified nodules and the size of the nodules varied from 50-500 
nm as indicated by the black arrows. Calcified nodules are seen to be deposited on the 
surface of the collagen fibers as well as the bone like tissue. The white arrows point to the 
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intimate interaction between the calcified nodules and the collagen fibers produced by 
cells.                             
Also, we could observe the connection of pores via collagen fibers. The EDX analysis of 
the calcified nodules confirms the secretion of inorganic bone mineral (hydroxyapatite) 
by the cells with a Ca/P ratio equal to 1.67 (Fig.11).  
 
 
Figure 11. EDX analysis of the interaction between the calcified nodules and the collagen 
fibers secreted by the cells. EDX analyses indicated that the calcified nodules are 
composed of mineralized hydroxyapatite with a Ca/P ratio equal to 1.67. 
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A dense layer of calcified matrix could be observed within a crack in the pore wall of the 
material (Fig. 12). Beneath the crack we could observe spherical shaped particles as 
indicated by the white arrow. A significant difference could be observed in the 
morphology of the particles secreted by the cells and the ceramic particles used in the 
study. The ceramic particles are irregular shaped whereas the calcium phosphate particles 
secreted by the cells are spherical in shape.   
 
10µ
Figure 12. Indicating an area under the crack in the cell layer within the pore wall of 
PLGA-B-HA composite seeded with cells. The figure describes the formation of a layer 
of tissue within the area under a crack.  
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Figure 13 indicates the EDX analysis of the area under the crack within the cell layer in a 
pore. The EDX analysis indicates the Ca:P ratio of the cell layer to be 1.66 closer to the 
inorganic component of bone.  
 
 
Figure 13.  EDX analysis of an area under a crack in the cell layer within the pore wall.  
The EDX analysis indicates the high content of the Ca and P which indicates the cellular 
activity. The Ca/P ratio in this case was equal to be 1.66 that indicates that the ratio is 
close to the natural hydroxyapatite material. 
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3.2 Main study  
3.2.1 Effect of the chemical composition on the morphology of 1:1, 1:2 and 1:3 
PLGA-B-HA composites 
3.2.1.1 Qualitative analysis of surface roughness using SEM  
Comparing the morphologies of 1:1, 1:2 and 1:3 we observe that the samples are highly 
porous with the porosity varying from 40-1000 µ (Fig. 14, Fig. 15 and Fig. 16). 1:1 
PLGA B-HA composite indicated the presence of comparatively thinner pore wall with 
an average thickness of 85 µ. The pore walls are indicated by the black arrows (Fig. 14). 
 
1mm 
Figure 14. The figure shows the external morphology of 1:1 PLGA-B-HA composite. 
The figure indicates the composite is highly porous with the pore size varying from 40 - 
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1000µ. The inner surface of the composite is also highly porous with the pore size 
varying from 10-90 µ as indicated by the white arrows. The pore walls are significantly 
(p < 0.05) thinner and are indicated by the black arrows. The average pore wall thickness 
of the 1:1 PLGA-B-HA composite is equal to 85µ. 
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Smaller pores as indicated by the red arrows within the pores with a pore size range 
varying from 10-90 µ could be observed. The pore walls of 1:2 PLGA-B-HA composite 
are thicker as compared to 1:1 PLGA-B-HA composites and are indicated by black 
arrows (Fig. 15). The pore size varied in the range 60-1000 µ.Also, in 1:2 PLGA-B-HA 
composite, smaller pores as indicated by the red arrows could be observed within the 
pore walls of the larger pores. The smaller pores varied in the size range from 10-40 µ. 
The average pore wall thickness of 1:2 PLGA-B-HA composite equals 130 µ 
 
1mm 
Figure 15. The figure shows the external morphology of 1:2 PLGA-B-HA composite. 
The figure indicates that the composite is highly porous with the pore size varying from 
60 - 1000µ. The inner surface of the composite is also highly porous with the pore size 
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varying from 10-40 µ as indicated by the white arrows. The pore walls are significantly 
(p < 0.05) thicker as compared to 1:1 PLGA-B-HA composites and are indicated by the 
black arrows. The average pore wall thickness of the 1:2 PLGA-B-HA composite equals 
130µ. 
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Thicker pore walls could be observed in 1:3 as compared to 1:1 and 1:2 PLGA-B-HA 
composites and are indicated by arrows (Fig. 16). The pore size varied in the range 30-
1000 µ. The average pore wall thickness of the 1:3 PLGA-B-HA composite was equal to 
182 µ. Also, here absence of smaller pores within the pore walls could be observed.  The 
composites appear to be rougher as compared to 1:1 and 1:2 PLGA-B-HA composites. 
1:2 PLGA-B-HA composites appear to be rougher than 1:1 PLGA-B-HA composites. 
 
1mm 
Figure 16. The figure shows the external morphology of 1:3 PLGA-B-HA composite.  
The figure indicates the composite is highly porous with the pore size varying from 30 - 
1000µ. Here no inner pores could be observed as indicated by the white arrow. The pore 
walls are significantly (p < 0.05) thicker as compared to 1:1 and 1:2 PLGA-B-HA 
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composites and are indicated by the black arrows. The average pore wall thickness of 
the1:3 PLGA-B-HA composite equals 182µ. 
 
 
Table1. Indicates the average pore wall thickness of 1:1, 1:2 and 1:3 PLGA-B-HA 
composites. The results indicate a significant increase in the pore wall thickness in the 
order of 1:3 > 1:2 > 1:1 could be observed. 
 
SAMPLES  PORE WALL 
THICKNESS 
p-VALUES 
1:1 & 1:2 
p-VALUES  
1:1 &1:3 
p-VALUES  
1:2 & 1:3 
1:1 85±29.155    
1:2 130±49.22 0.025 0.00032 0.04 
1:3 182±57    
 
Table 1. Indicates average pore wall thickness of 1:1, 1:2 and 1:3 PLGA-B-HA 
composites.  The table also provides a statistical comparison of the average pore wall 
thickness of the 1:1, 1:2 and 1:3 PLGA-B-HA composites. 
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3.2.1.2 Quantitative analysis of surface roughness using the “New View 5000” 
Quantitative analysis of surface roughness was done using the “New View 5000” 
scanning white light interference microscope.  
 
Figure17. Represents the surface of 1:1 PLGA-B-HA composite. The arrow indicates the 
area to be scanned.  
 
 
Figure 17. The color contour is represented by the micron scale and varies from -7.9 to + 
18.7 µm. The positive value corresponds to the peaks whereas the negative value 
corresponds to the valleys. The peaks are indicated by the green, yellow and red areas. 
The valleys are indicated by the blue areas.  
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Fig. 18, Fig.21 and Fig. 24 describes the oblique plots of randomly selected areas on 1:1, 
1:2 and 1:3 PLGA-B-HA composites respectively. Fig.18. indicates the presence of peaks 
indicated by the green lines. The scanning depth of the selected area varied from -1.46 to 
+1.8 µm. Few peaks with increased heights up to 1.8 µm could be seen on the surface and 
are indicated by red lines. The valleys are indicated by the blue lines.  
 
Figure 18. The figure shows an oblique plot representing a randomly chosen area on 1:1 
PLGA-B-HA composite. The selected area is marked as shown by the arrow (Fig. 17). 
The thickness of the area varies from -1.46 to +1.8 µm. The negative sign indicates the 
valleys and the positive sign indicates the presence of peaks on the surface. The red lines 
indicate the presence of higher peak heights up to +1.8 µm and not too many peaks could 
be observed here. Majority of the peaks are approximately of height 1.6 µm are indicated 
by the green lines. The valleys correspond to the blue lines. 
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Fig. 19, Fig. 22 and Fig. 25 indicate the 2-d profiles of the selected areas corresponding 
to 1:1, 1:2 and 1:3 PLGA-B-HA composites. Fig. 19 shows the presence of narrower 
peaks. 
 
 
Figure 19.  Figure indicates a 2-D profile of a randomly chosen area on 1:1 PLGA-B-HA 
composite as indicated by the arrow (Fig. 17).  The figure indicates the presence of 
narrower peaks. 
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Figure 20. Represents the surface of 1:2 PLGA-B-HA composite. The arrow indicates the 
area to be scanned. 
 
Figure 20. The color contour is represented by the micron scale and varies from -35.36 to 
+ 25.43 µm. The positive value corresponds to the peaks whereas the negative value 
corresponds to the valleys.  The peaks are indicated by the green, yellow and red areas. 
The valleys are indicated by the blue areas.  
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Fig.21 indicates the presence of larger number of peaks with a considerable increase in 
the peak heights ranging from -3.5 to +2.135 µ. Peaks are indicated by the green and red 
lines. The blue lines correspond to the valleys. 
 
Figure 21. The figure shows an oblique plot of a randomly chosen area on 1:2 PLGA-B-
HA composite. The selected area is marked as shown by the arrow (Fig.20). The 
thickness of the selected area varies from -3.5 to +2.135 µm. The negative sign indicates 
the valleys and the positive sign indicates the presence of peaks on the surface. Large 
number of peaks with increased peak heights up to 2.135 µm could be observed on 1:2 as 
compared to 1:1 PLGA-B-HA surface. The peaks are indicated by the red and green lines 
whereas the valleys correspond to the blue lines. 
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Fig. 22 showed an increase in the peak height and width as the ceramic concentration was 
increased as compared to 1:1 PLGA-B-HA composites.  
 
 
Figure 22. Figure indicates a 2-D profile of a randomly chosen area on 1:2 PLGA-B-HA 
composite as indicated by the arrow (Fig. 20). As the ceramic concentration was 
increased, an increase in the peak width and height up to 3.5 µm could be observed. 
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Fig.23. represents the surface of 1:3 PLGA-B-HA composite. The arrow indicates the 
area to be scanned.  
 
 
Figure 23.  The color contour is represented by the micron scale and varies from -39.5 to 
+30 µm. The positive value corresponds to the peaks whereas the negative value 
corresponds to the valleys. The peaks are indicated by the green, yellow and red areas. 
The valleys are indicated by the blue areas.  
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Fig.24 indicates An increase in the number of peaks with heights varying from -2.8 to 
+2.065 µ and are indicated by the red, yellow and green lines on the 1:3 PLGA-B-HA 
surface. The valleys are indicated by the blue lines. 
 
 
Figure 24. The figure shows an oblique plot of a randomly chosen area corresponding to 
1:3 PLGA-B-HA composite. The selected area is marked as shown by the arrow (Fig. 
23). The thickness of the selected area varies from -2.8 to +2.065 µm. The negative sign 
indicates the valleys and the positive sign indicates the presence of peaks on the surface. 
Here larger number of peaks with increased peak heights up to 2.065 µ could be 
observed. The surface appears to be rougher due to the increase in the number of peaks as 
compared to 1:1 and 1:2 PLGA-B-HA composites. The peaks are indicated by the red 
yellow and green lines. The valleys correspond to the blue lines. 
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Fig. 25 indicates a considerable increase in the peak heights and widths in case of 1:3 
PLGA-B-HA composites.  
 
 
Figure 25. Figure indicates a 2-D profile of a randomly chosen area on 1:3 PLGA-B-HA 
composite as indicated by the arrow (Fig. 23).  As the ceramic concentration is further 
increased a significant increase (p < 0.05) in the peak width and height up to 4 µm could 
be observed. After a certain scanning length i.e. between 30- 50 µ not many valleys could 
be observed.   
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The results indicate significantly higher (p < 0.05) average (Ra) values of roughness for 
1:3 as compared to1:1 and 1:2 PLGA-B-HA composites (Table 2). The Ra values 
increased in the order 1:3 > 1:2 > 1:1. 
 
SAMPLES  Ra (µM) Rrms (µM) SAMPLE 
COMPARISON
p-Ra p-Rrms  
1:1 5.022±3.364 6.77±4.406 1:1 &1:2 0.007 0.007 
1:2 10.11±2.851 13.641±3.5 1:1&1:3 0.00024 0.00024 
1:3 13.6±1.762 17.145±2.14 1:2 &1:3 0.0032 0.0032 
 
Table 2. Indicates average roughness values of 1:1, 1:2 and 1:3 PLGA-B-HA composites 
respectively. The table also provides the statistical comparison of the average roughness 
values of 1:1, 1:2 and 1:3 PLGA-B-HA composites. 
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3.2.2   FTIR analysis  
 
 
Figure 26. FTIR spectra of 1:1. 1:2 and 1:3 PLGA-B-HA composites. The functional 
groups corresponding to the polymer (PLGA) and ceramic (HA) are indicated in Table 3.  
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Table. 3 summarizes the IR bands corresponding to the polymer and the ceramic 
respectively. The areas under the ceramic and polymer peaks were analyzed and 
compared for 1:1, 1:2 and 1:3 PLGA-B-HA composites.  
 
IR BANDS 
(cm-1) (PLGA) 
ASSIGNMENTS IR BANDS (cm-1) 
(HA) 
ASSIGNMENTS 
1453 C-H(CH3) groups 1090,1042 P-O(PO4) groups 
1348,1388 C-H(CH3) groups 962 P-O (PO4) groups 
1269 C-H and C-O 872 P-OH (HPO4) groups 
1189 C-O 627 O-H (OH) group 
  602,567 P-O(PO4) groups 
  471 P-O(PO4) groups 
 
Table 3. Infrared vibrational frequencies of PLGA and HA in the 2000-1000 cm-1 and 
2000-400 cm-1 region.  
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3.2.3 Mechanical testing  
Table 4 summarizes the compressive modulus and failure strain of 1:1, 1:2 and 1:3 
PLGA-B-HA composites respectively. The table also provides a comparison of 
compressive strengths and modulli of PLGA-PCL-HA, PLGA-HA and PLGA-PCL 
composites with trabecular bone. Both, the compressive modulus and compressive yield 
strength of 1:1 are significantly higher (n = 3, p < 0.05) than those of 1:2 and 1:3 PLGA-
B-HA composites respectively. Compressive strength and compressive modulus of 1:2 
are significantly higher (p < 0.05) than 1:3 PLGA-B-HA composites.  
POLYMER-CERAMIC 
COMPOSITES 
COMPRESSIVE 
STRENGTH  
FAILURE 
STRAIN  
COMPRESSIVE 
MODULUS  
1:1 0.36±0.055 0.145±0.0035 2.5±0.32 
1:2 0.07±0.026 0.16±0.007 0.42±0.15 
1:3 0.045±0.02 0.15±0.013 0.3±0.12 
 
Table 4.  The compressive modulus and yield strength of 1:1, 1:2 and 1:3 PLGA-B-HA 
composites prepared from the freeze drying lyophillization technique.  
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3.2.4 Biochemical Assays  
3.2.4.1 Total protein analysis  
Minimal difference (n = 4, p > 0.05) in the protein concentration secreted by the bone 
marrow stem cells on to 1:1, 1:2 and 1:3 PLGA-B-HA composites could be observed at 
the end of 10 and 30 days (Fig. 27). At the end of 20 days cells attached to the surface of 
1:2 and 1:3 PLGA-B-HA composites produced significantly (p < 0.05) higher protein 
concentration (µg/ml) as compared to  1:1 PLGA-B-HA composites. No significant 
difference (p > 0.05) in the protein concentration produced by the cells cultured on to 1:2 
and 1:3 PLGA-B-HA composites at the end of 20 days could be observed. 
 
Figure 27. Indicates the concentration of the protein in µg/ml produced by the rat marrow 
cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites at 10, 20 and 30 days 
respectively. The results show no significant difference in the protein concentration 
(µg/ml) produced by the cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites at 
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the end of 10 days. At the end of 20 days, cells cultured on to 1:2 and 1:3 PLGA-B-HA 
surfaces produced significantly higher ( n = 4, p < 0.05) protein as compared to 1:1 
PLGA-B-HA surfaces.  No significant difference (p > 0.05) in the protein concentration 
produced by the cells cultured on 1:2 and 1:3 PLGA-B-HA composites at the end of 20 
days could be observed. At the end of 30 days no significant difference (p > 0.05) in the 
protein concentration produced by the cells cultured on 1:1, 1:2 and 1:3 PLGA-B-HA 
composites could be observed. 
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3.2.4.2 Alkaline phosphatase assay  
Fig. 28 shows the AP activity in nmol of pNP/min/µg protein and protein concentrations 
produced by rat marrow cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites for 
a period of 10, 20 and 30 days respectively. The results of the 10 and 20-day experiment 
indicated no significant difference (n = 4, p > 0.05) in the AP activities on 1:1, 1:2 and 
1:3 PLGA-B-HA composites respectively. The results of the 30-day experiment indicated 
the bone marrow stem cells expressed significantly higher alkaline phosphatase (n = 4, p 
< 0.05) on 1:3 as compared to 1:1 and 1:2   PLGA-B-HA composites. No significant 
difference (p > 0.05) could be observed in the alkaline phosphatase activities of rat 
marrow stem cells on to 1:1 and 1:2 PLGA-B-HA composites at the end of 30 days 
respectively. 
         
Figure 28. AP activity in nmol of pNP/min/µg protein produced by rat marrow stem cells 
on 1:1, 1:2 and 1:3  PLGA-B-HA composites at the end of 10, 20 and 30 days. The figure 
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represents the AP activity (nmol of pNP/min/µg protein) and protein concentrations 
(µg/ml) produced by rat marrow cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA 
composites at the end of 10, 20 and 30 days respectively. At the end of 10 days, no 
significant difference ( n = 4, p > 0.05) could be observed in the AP activity and protein 
concentrations on 1:1, 1:2 and 1:3 PLGA-B-HA composites. At the end of 20 days, no 
significant difference (p > 0.05) in AP activity produced by the cells on 1:1, 1:2 and 1:3 
PLGA-B-HA composites could be observed. At the end of 30 days cells expressed 
significantly (p < 0.05) higher AP on 1:3 as compared to 1:1 and 1:2 PLGA-B-HA 
composites. 
 
 62
3.2.4.3Osteocalcin  
Osteocalcin concentration in absorbance units of 1:1, 1:2 and 1:3 PLGA-B-HA 
composites and control samples were measured at the end of 14, 21 and 28 days 
respectively. The results indicated bone marrow stem cells seeded on to the 1:3 PLGA-B-
HA composites expressed significantly higher ( n =3, p < 0.05) osteocalcin at the end of 
14 and 21 days respectively. 1:2 expressed significantly higher (p < 0.05) osteocalcin 
secretion by osteoblasts at the end of 28 days as compared to 1:1 PLGA-B-HA 
composites and 1:3 PLGA-B-HA composites. Cells seeded on to the 1:1 PLGA-B-HA 
composites produced significantly lower (p < 0.05) osteocalcin as compared to 1:2 and 
1:3 PLGA-B-HA composites at the end of 28 days respectively (Fig. 29).  
 
Figure 29.  Osteocalcin concentration in absorbance units of 1:1, 1:2, 1:3 PLGA-B-HA 
composites and control samples at the end of 14, 21 and 28 days respectively.  
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3.2.5 Corrosion studies in tissue culture medium  
3.2.5.1 Ca concentration at the end of 28 days  
ICP analysis showed minimal difference ( n = 4, p > 0.05) in the Ca concentrations  of 
the tissue culture media incubated with or without various PLGA-B-HA samples at the 
end 7, 14, 21 and 28 days (Fig. 30).  
   
Figure 30. ICP measurements of Ca concentrations in the media incubated with PLGA-
B-HA composites (1:1, 1:2, 1:3) and control samples incubated in polystyrene culture 
dishes for 7, 14, 21 and 28 days respectively in the presence of bone marrow stem cells.   
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3.2.5.2 P concentration at the end of 28 days  
ICP analysis showed minimal difference ( n = 4, p > 0.05) in the P concentrations 
between the PLGA-B-HA composites and cells incubated in polystyrene dishes at the end 
7, 14, 21 and 28 days respectively (Fig.31)   
           
 
Figure 31.  ICP measurements of  p concentrations in the media incubated with PLGA-
B-HA composites (1:1, 1:2, 1:3) and control samples incubated in polystyrene culture 
dishes for 7, 14, 21 and 28 days respectively in the presence of bone marrow stem cells. 
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3.2.6 pH measurements at the end of 28 days   
pH values of 1:1, 1:2, 1:3 PLGA-B-HA composites and control samples incubated in 
polystyrene dishes in the presence of bone marrow stem cells at the end of 7, 14, 21 and 
28 days respectively were measured. Results indicate a minimal difference (p > 0.05) in 
the pH values of the composites and cells incubated in polystyrene dishes in tissue culture 
medium at the end of 28 days (Table 5). 
 
COMPOSITIONS 
21ST DAY 
MEAN ± 
STDV.  
21ST DAY 
COMPOSITIONS 
28TH DAY 
MEAN ± 
STDV. 
28TH DAY 
1:1  7.67 ± 0.06 1:1  7.5 ± 0.051 
1:2  7.7 ± 0.042 1:2  7.54 ± 0.042 
1:3  7.6 ± 0.1 1:3  7.62 ± 0.07 
CONTROL   7.7 ± 0.14 CONTROL   7.33 ± 0.053 
 
Table 5.  pH values of the tissue culture media containing 1:1, 1:2, 1:3 PLGA-B-HA 
composites and control samples incubated in polystyrene dishes at the end of 21 and 28 
days respectively. 
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CHAPTER FOUR  
DISCUSSION  
4.1 Pilot study  
4.1.1 Significance of Bovine bone hydroxyapatite  
To engineer an ideal scaffold has prompted us to synthesize a macroporous polymer-
ceramic composite with an appropriate ratio of the bioresorbable polymer to the bioactive 
ceramic that could enhance osteoblast function. In our study we have employed porous 
bovine hydroxyapatite to synthesize the polymer-ceramic composite.  
 
4.1.2 Significance of the copolymer ratio 
The polymer used in the study was PLGA 50:50; Mw = 72000Da. The polymer was 
chosen due to controlled degradation and good mechanical properties. Degradation rate 
of the polymer can be controlled by altering the copolymer ratio and the molecular 
weights.  Below a molecular weight of 10,000, PLGA foams had very little mechanical 
strength [57].  
 
4.1.3 Significance of Freeze-drying technique  
The PLGA-BHA composite synthesized using the Freeze-drying lyophilization technique 
[43-46, 57-60] allowed for highly porous structure with a pore size varying from 40-1000 
µm as indicated by the arrows in (Fig. 1). In this procedure, two phases- a polymer-rich 
phase and a polymer-lean phase are formed by cooling down the polymer solution 
thereby inducing a liquid-liquid phase separation. The solvent is then extracted by 
placing it in a vacuum chamber and the solvent removal leads to the formation of the 
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macropores. Chloroform was preferred instead of dioxane due to its lower freezing 
temperature. As the ceramic concentration was increased, foams synthesized using 
dioxane as a solvent were rigid and microporous. The optimal pore size for bone grafting 
is in the range of 100-350 µm [43]. The PLGA-BHA material prepared in the present 
study satisfies most the requirement of the ideal pore size for osteoblasts infiltration, 
viability and function. SEM analyses indicated that PLGA-composite is marcoporous and 
had interconnected open pore morphology. SEM (Fig 7.) analysis indicated that neonatal 
rat calvaria osteoblasts attached to the surface of PLGA-B-HA.  Also the composite is 
highly porous with the porosity varying from 30-1000 µ. This matches the requirement of 
the ideal pore size required for the promoting osteoblast viability and function.  
 
4.1.4 Significance of cell-material interactions  
Cell adhesion is an important aspect of cell interaction with a biomaterial since it is 
required for cell proliferation, differentiation and cell spreading on to the material 
surface. Cell adhesion and spreading are two distinct phenomenon’s because it has been 
shown that the substrates that allow cell adhesion do not necessarily promote cell 
spreading. The initial osteoblast/material interactions are characterized by four stages: (1) 
protein adsorption to the surface, (2) contact of cells with the surface, (3) cell attachment 
and (4) cell spreading. The 90-min time would reflect the interactions involving the first 
contact of the cell with the substrate followed by the attachment on the substrate. Initial 
spreading occurs at the end of 4h which is characterized by reorganization of the 
cytoskeletal matrix and flattening of the cell. At the end of 24 hours the cells are expected 
to be flat and spread and to have started proliferating. There are no fixed time periods that 
 68
characterize the cell morphology as the cell morphology changes with the type of the 
substrate and also the type of the cell used [61]. 
 
After attachment to the PLGA-BHA the cells produced extensive mineralized ECM at the 
end of 2 weeks. The EDX ratio (Fig. 8, Fig. 10 and Fig. 12) indicates the presence of 
biological HA with the Ca/P ratio equal to 1.66. On the other hand (Fig. 5) indicated the 
cells on HA discs produced collagenous matrix. Also in some areas we could observe the 
collagen fibers merging to form a continuous sheet of ECM (Fig. 6). However, no 
inorganic matrix was produced by the cells attached to HA which could be seen by the 
absence of calcified nodules.  While the HA discs stimulated the formation of un 
mineralized organic matrix, the PLGA-B-HA composites stimulated both the formation 
of organic as well as the inorganic matrix. This could be seen by the presence of calcified 
nodules (Fig. 7 and Fig. 9). Cells appear to be somewhat flat when cultured on to the 
surface of PLGA/PCL/HA composites at the end of 2 weeks [62].  
 
However in our study we observed comparatively extensive mineral secretion by 
neonatal rat calvarial osteoblasts cultured on to PLGA-B-HA composites at the end of 2 
weeks. The results of the pilot study indicated higher cellular activity on PLGA-B-HA 
composites as compared to pure HA discs. Higher osteoconductivity of B-HA is due to 
the similar mineral content or inorganic portion of the ceramic as that of the bone. Even 
though the inorganic component of Interpore 200 is similar to that of the inorganic 
portion of natural bone, the porosity when compared to B-HA is different. We have 
evaporated the organic component from the bovine bone thereby leading to the formation 
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of a porous structure. The porosity of the ceramic (B-HA) provides larger surface area 
thereby increasing cell attachment, facilitating cell infiltration and extracellular formation 
as observed from the SEM (Fig. 8 and Fig. 10). .  
 
Hence the results of the pilot study have prompted us to further expand and evaluate the 
effect of varying the ceramic concentration on the stimulation of osteoblastic activity.   
 
4.2 Main study  
4.2.1 Significance of surface topography  
Surface modification of biomaterials has been one of the major factors in the 
development of tissue engineering. As a scaffold, the significance of biomaterials is that 
they can not only interact with the cells but also with the host environment, through the 
interface. Immobilization of bioactive molecules on the surface of the substrate would 
mediate cell behavior. Such differences in topographies contribute to the changes in 
hydrophobicity/hydrophilicity balance. On the other hand, such differences also led to the 
differences in deposition of serum proteins. It is generally known that the 
hydrophobicity/hydrophilicity of a film surface can affect the degree of cell adhesion and 
proliferation. Hydrophilicity is a factor affecting surface energy, which might influence 
serum proteins that adhered to these materials and in turn influence cell proliferation and 
differentiation [61]. It has been observed that the topography of a porous surface 
enhances migration by physically directing tissue movement [62].  
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Lactic acid is more hydrophobic than glycolic acid, and increase in its concentrations 
increases hydrophobicity. An increase in hydrophobicity corresponds to the decrease in 
degradability. PLGA is amorphous in nature and hence the copolymer matrices degrade 
at a relatively high rate. An increase in PLA or PGA content in PLGA will increase the 
crystallinity of the polymer and hence the degradation time [64]. Migration of the cells on 
to the porous surface was dependent on the surface chemistry. It has also been reported 
that hydrophilic surfaces exhibit greater cellular adhesion over hydrophobic surfaces [64-
66]. Sato et al. showed exposure of HA and/or TiO2 particles in PLGA+TiO2 
precursor+HA coatings after decomposition of PLGA due to hydrolysis increased coating 
hydrophilicity [67]. Also it has been reported that surface roughness leads to an increase 
in adhesion of bone forming cells, indicating the remodeling activity [67-72]. Schwartz et 
al. studied that the microrough topography of titanium implants exhibited increased pull 
out strength in vivo suggesting increased implant-tissue adhesion. In vitro studies further 
revealed that as the surface microroughness is increased, osteoblast proliferation is 
decreased whereas differentiation is increased [72]. Anselme et al. qualitatively evaluated 
the adhesion of human osteoblasts on orthopedic metallic substrates with various surface 
roughnesses and its correlation with qualitative changes in the expression of adhesive 
proteins and with parameters describing the surface topographies [73]. It was shown that 
the cell layer organization was modified by the roughness of the material surfaces thereby 
initiating cell differentiation [73-75]. 
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4.2.2 Effect of the chemical composition on the morphology of 1:1, 1:2 
and 1:3 PLGA-B-HA composites  
4.2.2.1 Surface roughness characterization  
4.2.2.1.1 Qualitative analysis of surface roughness  
Fabrication parameters such as ceramic to polymer concentration and water to solvent 
ratio were varied to arrive at reproducible targeted macroporous structures. From the 
SEM we can clearly observe a difference in the pore wall thickness and porosity in case 
of 1:1, 1:2 and 1:3 PLGA-B-HA composites (Fig. 13, Fig. 14 and Fig. 15). A significant 
increase (p < 0.05) in the pore wall thickness in the order of 1:3 > 1:2 > 1:1 could be 
observed (Table 1). The thicker pore walls of 1:3 PLGA-B-HA may be due to the higher 
concentration of the ceramic. There might be due to the ceramic particles that are loosely 
adhered on to the pore walls of the composite. We could observe an increase in ceramic 
concentration decreases the porosity as observed in case of 1:3 PLGA-B-HA composites. 
This is due to the decrease in the volume of the solvent due to the increase in ceramic 
concentration.  
 
4.2.2.1.2 Quantitative analysis of surface roughness  
Characterization of the changes in surface topography was done using the “New View 
5000” scanning white light interference microscope. For analyzing the changes in surface 
topography the sample surface has to be extremely reflective.  Specific regions within a 
reflective surface are selected and are converted to corresponding data points thereby 
creating an image which is eventually displayed on a computer screen. Certain areas were 
selected on the surface of 1:1, 1:2 and 1:3 polymer-ceramic composites respectively (Fig. 
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16, Fig. 19 and Fig. 22) and by a command called ‘MASK’ we highlighted the specific 
areas and captured the 2-D and 3-D profiles respectively. We have analyzed 10 different 
areas on the pore walls of different compositions (1:1, 1:2 and 1:3 respectively) and 
computed the average, rms and peak roughness values. The average, peak and the rms 
values varies position by position on the sample surface indicating a change in the 
topography.  
 
The results indicate that the average roughness values (µm) in the order of 1:3 > 1:2 > 
1:1. Table 1. indicates a significant increase (n = 3, p < 0.05) in the pore wall thickness in 
the order of 1:3 > 1:2 > 1:2 PLGA-B-HA composites. Fig. 17, Fig. 20 and Fig. 23 
indicate an oblique plot of a specific area (Fig. 16, Fig. 19 and Fig. 22) on 1:1, 1:2 and 
1:3 PLGA-B-HA composites respectively. The peaks are indicated by the red and the 
green lines whereas the valleys are indicated by the blue lines. As the concentration of the 
ceramic is increased an increase in the area under the peak is observed. The scanning 
depth on the surface was 50 µm. The maximum peak height from the line profile for 1:1 
was 1 µm, whereas for 1:2 and 1:3 it was 3.4 and 4 µm respectively. As the concentration 
of the ceramic is increased due to deposition of ceramic on to the surface, the height of 
the peak is increased as seen by the 2-D profile with an increase in the width (Fig. 18, 
Fig. 21, and Fig. 24). The increased width represents the increased ceramic concentration 
thereby covering some valleys.  
 
Pore wall roughness indicates a variation in surface topography. Higher variation in 
topography gives a higher peak to valley value. Also higher Ra value indicates higher 
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roughness. 2-D profiles quantify the roughness and compare the changes in topography 
on different areas within the same sample as well within different samples. 1:1 represents 
a comparatively smoother surface indicating lesser magnitude of the peak to valley 
distance. 1:2 indicates a significantly higher peak to valley distance indicating a bumpier 
surface as compared to 1:1. When analysis was done on 1:3 PLGA-B-HA composite it 
showed significantly higher (p < 0.05) roughness as compared to 1:2 and 1:1 PLGA-B-
HA composites respectively. The surface roughness was increased due to the ceramic 
concentration. Ceramic (B-HA) is rough in nature and an increase in ceramic 
concentration led an increase in surface roughness.  Niederauer et al. showed that surface 
roughness, for osteoceramic materials, improved surface wetting properties [76]. This can 
further promote cell adhesion on to the biomaterial via formation of focal contacts or 
indirectly through selective adsorption of osteoinductive proteins favoring cell adhesion. 
The surface energy of hydroxyapatite significantly influences cell adhesion and spreading 
of human osteoblastic cells at the surface [77]. Hence an increase in hydroxyapatite 
concentration is indicated by the increase in the surface roughness. An increase in surface 
roughness contributes to the increase in the surface area thereby favoring cellular 
attachment.
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4.2.3 FTIR analysis  
Table 3 indicates the characteristic peaks in the region 1500-1000cm-1 and 1000-400 cm-1 
for the polymer and hydroxyapatite respectively [78]. FTIR analysis indicated the 
presence of the ceramic phase as observed by the characteristic bands of PLGA and HA 
(Fig. 25). An increase in the area under the ceramic phase could be observed in case of 
1:3 as compared to 1:1 and 1:2 PLGA-B-HA composites.  
 
The results indicate an increase in the ceramic concentration, increases the area under the 
ceramic peak thereby increasing the ratio of the area measured under the ceramic to 
polymer (Fig. 25). The IR bands corresponding to the ceramic peaks are located at 567, 
602 cm-1 and 962 cm-1, representing the P-O (PO4) groups and 627 cm-1 representing the 
O-H groups respectively. The IR bands corresponding to the polymer peaks are located at 
1453 cm-1 representing C-H (CH3), C-H and at 1269 cm-1 corresponding to C-O groups 
respectively. In the above study we have incorporated PLGA in to B-HA to modify the 
degradation as well as to improve the mechanical properties of the composite  
 
4.2.4 Mechanical testing  
For mechanical testing 3 samples were tested for each composition. The samples were 
tested under compression. It was observed that the compressive strength and modulus of 
1:1 were significantly higher than those of 1:2 and 1:3 PLGA-B-HA composites. The 
polymer-ceramic composite is synthesized using the freeze drying/lyophilization 
technique. The polymer in this case forms a supporting matrix to which the ceramic 
particles adhere. An increase in the ceramic concentration or a decrease in the polymer 
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concentration gives rise to loosely attached ceramic particles. The particles are loosely 
bounded and have a tendency to shed off from the surface of the composite. For 1:2 and 
1:3 PLGA-B-HA composites significant leaching of the ceramic particles could be 
observed. Hence this lowers the ceramic concentration and as the polymer concentration 
is less as compared to 1:1 PLGA-B-HA composites, we could observe a significant 
decrease in the compressive strengths and modulli of 1:2 and 1:3 PLGA-B-HA 
composites. The results indicate that the optimal ratio between the polymer and the 
ceramic is important in improving the mechanical properties, particularly the mechanical 
strengths. The composite will allow us to modify the mechanical properties by optimizing 
the molecular weights and the ratio of the polymer to the ceramic incorporated during the 
fabrication process.  
 
4.2.5 Bioactivity evaluation  
4.2.5.1 Alkaline phosphatase assay 
Alkaline phosphatase activity is a characteristic marker of early osteoblastic 
differentiation.  We have analyzed the alkaline phosphatase activity of bone marrow stem 
cells cultured on to 1:1, 1:2, 1:3 PLGA-B-HA composites and control samples incubated 
in polystyrene dishes immersed in tissue culture media over a period of 10, 20 and 30 
days. A significant difference (n = 4, p < 0.05) in the AP activity of 1:3 over 1:1 and 1:2 
PLGA-B-HA composites at the end of the 30-day period whereas no significant 
difference (p > 0.05) were observed at the end of 10 and 20 days (Fig. 28). Protein 
concentration (µg/ml) indicates no significant difference (p > 0.05) secreted by the rat 
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marrow stem cells on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the end of 30 days 
(Fig. 27).  
 
Tiffitt et al. showed the alkaline phosphatase staining demonstrated stimulation of this 
marker of the osteogenic phenotype in the cultures grown with the cements compared 
with human bone marrow stem cells cultured on plastic alone [79]. The results indicated 
that alkaline phosphatase produced by cells increased significantly when grown in the 
presence of calcium phosphate cements. Enzyme expression was increased in cells in 
contact with the surface of the carbonated apatite and 90% hydroxyapatite cements as 
compared to cells grown on plastic alone.  
 
4.2.5.2 Osteocalcin  
Osteocalcin or BGP (bone gla protein) is exclusively found in bone tissue. It accounts for 
10-20% of the non-collagenous protein in bone. While the in vivo function of osteocalcin 
is unknown, its affinity for bone mineral constituents implies a role in bone formation 
[80]. It is a characteristic marker of bone forming cells i.e. osteoblasts. Cells attached on 
to the surface of 1:3 PLGA-B-HA composites produced significantly higher osteocalcin 
as compared to 1:1 and 1:2 composites (Fig. 32). Also, here we could observe the cells 
produced osteocalcin at a relatively shorter period i.e. 14 days of time on the 1:3 as 
compared to 1:2 and 1:1 PLGA-B-HA composites respectively (Fig. 30). Cells produced 
higher osteocalcin on 1:2 PLGA-B-HA composites at the end of 28 days. At the end of 
28 days we could observe a significant decrease (p < 0.05) in the osteocalcin 
concentration in 1:3 PLGA-B-HA composites. No significant difference (p < 0.05) in the 
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osteocalcin concentrations could be observed on 1:1 PLGA-B-HA composites and cells 
incubated in polystyrene dishes at the end of 28 days respectively. 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Indicates the osteocalcin concentration on 1:3 PLGA-B-HA composites at a 
relatively short period of time as compared to 1:1, 1:2 PLGA-B-HA composites and 
control samples at the end of 14, 21 and 28 days respectively.  
 
Osteocalcin concentration produced by the cells on to 1:3 is significantly higher at the 
end of 14 days as compared to 1:2 and 1:1 PLGA-B-HA composites. Cells seeded on to 
1:3 PLGA-B-HA composites secreted higher osteocalcin and at a shorter period of time 
as compared to 1:2 and 1:1 PLGA-B-HA composites (Fig.32). Also cells seeded on to 1:2 
PLGA-B-HA composites secreted higher osteocalcin at the end of 21 days whereas no 
increase in osteocalcin could be observed for the cells seeded on to 1:1 and cells cultured 
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in polystyrene dishes at the end of 30 days respectively.  Hence it could be inferred that a 
higher ceramic (B-HA) concentration stimulates osteoblastic differentiation. Ma et al. 
studied the synthesis of highly porous biodegradable polymer-hydroxyapatite scaffolds. 
The results indicated that HA is osteoconductive and porous PLLA/HA scaffolds are 
superior to pure PLLA scaffolds for bone tissue engineering [43]. Cellular activity was 
determined using osteocalcin and bone sialoprotein measurements in tissue culture 
medium followed by DNA assay analysis. The osteocalcin concentration produced by the 
cells was high on to PLLA/HA scaffolds as compared to the PLLA scaffolds at the end of 
6 weeks. In our study the results indicated, higher ceramic concentration as in the case of 
1:3 PLGA-B-HA composite stimulated osteocalcin secretion at the end of 14 days. This 
indicates stimulation of osteoblast function at an earlier time period which is due to the 
increase in bovine hydroxyapatite concentration in the composite material.   
 
4.2.6 Corrosion studies in tissue culture medium  
ICP analyses indicate a minimal difference in Ca and P concentrations from 1:1, 1:2, 1:3 
PLGA-B-HA composites and control samples incubated in polystyrene dishes (p > 0.05) 
at the end of 7, 14, 21 and 28 days respectively (Fig. 30 and Fig. 31). From this we can 
infer that there was a minimal difference in the dissolution/precipitation of Ca and P from 
the degradation of PLGA-B-HA composites and that secreted from the osteoblasts. This 
also indicates that the concentration of Ca and P due to the degradation of PLGA-B-HA 
composite was similar to the Ca and P concentration produced by the activity of the bone 
marrow stem cells. Hence the presence of the PLGA-B-HA composite did not affect the 
ionic concentration of Ca and P.  
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The corrosion products of the material can deteriorate the cell activity due its toxicity 
effect or the adverse effect on pH. An increase or decrease in the environmental pH could 
be unfavorable to the cells and could hinder cell attachment and hence bone formation. 
The ideal pH value for tissue culture medium at 370C is 7.4. The pH values were 
measured at 25.20C.  No significant difference in pH was observed at the end of and 28 
days for PLGA-B-HA composites and control samples respectively (Table 5). Most 
importantly no significant difference (p > 0.05) could be observed in pH values for 1:1, 
1:2, 1:3 PLGA-B-HA composites and control samples incubated in polystyrene culture 
dishes at the end of 28 days were observed. Hence the presence of the composite did not 
affect the pH of the surrounding environment.  
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CHAPTER FIVE  
CONCLUSIONS 
 
1. We have engineered a novel porous B-HA-polymer ceramic composite and 
correlated the effect of an increase in ceramic concentration on to stimulation of 
mesenchymal stem cells to restrict to osteoblastic phenotypes. 
2. PLGA-B-HA composites were highly porous with an interconnected porous 
network which enhanced cell colonization.   
3. Composites with high ceramic concentration induced osteoblast differentiation as 
indicated by high AP activity, high osteocalcin concentration, and mineralized 
extracellular matrix formation.  
4. Increased surface roughness enhances cellular activity as indicated by 1:3 PLGA-
B-HA composites.  
5. The presence of the PLGA-B-HA composite did not affect the ionic concentration 
of Ca and P and the surrounding pH.  
6. A variation in the chemical composition affected the cellular activity of 
osteoblasts.  
7. An increase in ceramic concentration stimulated osteoblast function. 
8. PLGA-B-HA can serve as a suitable carrier for the delivery for BMSC’s.   
9. Use of bovine hydroxyapatite may induce higher bioactivity than other forms of 
hydroxyapatite.    
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FUTURE WORK  
 
The composites would be immersed in SBF to determine the bioactivity via ion 
exchange mechanisms. The total DNA content of the cells seeded on to 1:3 PLGA-B-
HA composites would be analyzed and the results would be compared with 1:1 and 
1:2 PLGA-B-HA composites. In vivo analysis would include subcutaneous 
implantation of macroporous, bioactive, 1:3 PLGA-B-HA composites loaded with 
bone marrow cells in rats. 
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